» Articles » PMID: 33865316

Viral Load and High Prevalence of HR-HPV52 and 58 Types in Black Women from Rural Communities

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2021 Apr 18
PMID 33865316
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The high-risk human papillomavirus (HR-HPV) infection is the main cause of cervical cancer development, and the most common types were included in the last approved nonavalent vaccine (9vHPV). Geographical, socioeconomic and ethnic barriers in developing countries challenge primary and secondary prevention measures of cervical cancer. We aimed to determine the prevalence of HPV infection and the viral load of HR-HPV 9vHPV-related types black women resident in rural semi-isolated communities.

Methods: A descriptive study was conducted with 273 cervical samples of women from rural communities of Southeastern Brazil. Viral DNA was amplified by PCR, the genotype was identified by Reverse Line Blot (RLB) and Restriction Fragment Length Polymorphism (RFLP), and real-time PCR was applied to determine the viral load.

Results: HPV frequency was 11.4% (31/273), associated with the presence of cytological abnormalities (32.3%; p < 0.001). Thirty-one distinct genotypes were detected; HR-HPV occurred in 64.5% (20/31) of the samples and the most prevalent type were HPV52 > 58, 59. Multiple infections occurred with up to nine different genotypes. The viral load of HR-HPV 9vHPV-related types was higher in lesions than in normal cytology cases (p = 0.04); "high" and "very high" viral load occurred in HSIL and LSIL, respectively (p = 0.04).

Conclusions: We highlight that despite the low HPV frequency in the black rural women population, the frequency of HR-HPV was high, particularly by the HR-HPV52 and 58 types. Moreover, the HR-HPV viral load increased according to the progression from normal to lesion, being a potential biomarker to identify those women at higher risk of developing cervical lesions in this population.

Citing Articles

Prevalence, Characteristics, and Distribution of Human Papillomavirus According to Age and HIV Status in Women of Eastern Cape Province, South Africa.

Mbulawa Z, Kondlo S, Toni S, Faye L, Businge C Viruses. 2024; 16(11).

PMID: 39599866 PMC: 11598844. DOI: 10.3390/v16111751.


High-risk HPV prevalence and genotype distribution among women in Liaocheng, Shandong Province, China from 2016 to 2022.

Zheng L, Chen S, Yang F, Wang W, Xu C, Zheng L Front Public Health. 2023; 11:1145396.

PMID: 37064671 PMC: 10098111. DOI: 10.3389/fpubh.2023.1145396.


Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening.

Yang Q, Du H, Qu X, Dai W, Gui L, Li C Front Public Health. 2022; 10:1010066.

PMID: 36438219 PMC: 9686283. DOI: 10.3389/fpubh.2022.1010066.

References
1.
Koressaar T, Lepamets M, Kaplinski L, Raime K, Andreson R, Remm M . Primer3_masker: integrating masking of template sequence with primer design software. Bioinformatics. 2018; 34(11):1937-1938. DOI: 10.1093/bioinformatics/bty036. View

2.
Estrade C, Menoud P, Nardelli-Haefliger D, Sahli R . Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J Clin Microbiol. 2011; 49(10):3474-81. PMC: 3187290. DOI: 10.1128/JCM.05039-11. View

3.
Adcock R, Cuzick J, Hunt W, McDonald R, Wheeler C . Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia. Cancer Epidemiol Biomarkers Prev. 2019; 28(11):1816-1824. PMC: 8394698. DOI: 10.1158/1055-9965.EPI-19-0239. View

4.
Winer R, Xi L, Shen Z, Stern J, Newman L, Feng Q . Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women. Int J Cancer. 2013; 134(8):1889-98. PMC: 3947429. DOI: 10.1002/ijc.28509. View

5.
Trottier H, Mahmud S, Costa M, Sobrinho J, Duarte-Franco E, Rohan T . Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2006; 15(7):1274-80. DOI: 10.1158/1055-9965.EPI-06-0129. View